Latest Luminex Corporation Stories
AUSTIN, Texas, May 7, 2013 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) announced today that management will present at three upcoming investment conferences: The UBS Global Healthcare Conference on Tuesday, May 21 at 1pm ET in New York City The Jefferies 2013 Global Healthcare Conference on Tuesday, June 4 at 1:30pm ET in New York City, and The Goldman Sachs 34(th) Annual Global Healthcare Conference on Tuesday, June 11 at 1:20pm PT in Rancho Palos Verdes The presentations...
Innovative multiplexing instrument for clinical laboratories with simultaneous testing for greater than 90% of bacterial, viral, and parasitic causes of infectious gastroenteritis in a single molecular test now available AUSTIN, Texas, April 15, 2013 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced it has received U.S. FDA clearance of its MAGPIX instrument, with its xTAG Gastrointestinal Pathogen Panel (xTAG GPP). This is the first clinical assay to be...
AUSTIN, Texas, April 8, 2013 /PRNewswire/ -- Luminex Corporation (Nasdaq: LMNX) today announced that it expects to report results for the first quarter of 2013 on Monday, April 29, 2013 after the close of trading. (Logo: http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO) Management will hold a conference call to discuss the operating highlights and financial results for the first quarter ended March 31, 2013 on April 29, 2013, at 5:00 p.m. Eastern time. The conference call will be...
AUSTIN, Texas, Feb. 4, 2013 /PRNewswire/ -- Luminex Corporation (NASDAQ:LMNX) today announced financial results for the fourth quarter and year ended December 31, 2012. Financial and operating highlights include the following: Consolidated fourth quarter revenue of $55.5 million, a 16 percent increase over the fourth quarter of 2011; full-year 2012 revenue was $202.6 million, a 10 percent increase over 2011 Fourth quarter assay revenue of $23.8 million, a 45 percent increase...
AUSTIN, Texas, Jan. 31, 2013 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced that management will present at the Leerink Swann Global Healthcare Conference to be held February 13 -14, 2013, in New York, NY. (Logo: http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO) The investor presentation by Patrick J. Balthrop, president and chief executive officer, will begin at 11:30 a.m. Eastern time on Thursday, February 14, 2013. The presentation will be webcast live...
AUSTIN, Texas, Jan. 16, 2013 /PRNewswire/ -- Luminex Corporation (Nasdaq: LMNX) today announced that it expects to report results for the fourth quarter of 2012 on Monday, February 4, 2013. A press release announcing the results is scheduled for release after the close of trading. (Logo: http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO) Management will hold a conference call to discuss the operating highlights and financial results for the fourth quarter and twelve months...
The Academy of Medicine, Engineering and Science of Texas (TAMEST) announces the appointment of Sara Ortwein, president of ExxonMobil Upstream Research Company (URC), as chair of their Industry and Community Affiliates (ICA) Committee. Austin, Texas (PRWEB) January 15, 2013 Sara N. Ortwein, president of ExxonMobil Upstream Research Company (URC), has been appointed chair of the Industry and Community Affiliates (ICA) Committee of The Academy of Medicine, Engineering and Science of Texas...
AUSTIN, Texas, Jan. 15, 2013 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) announced today that it has received FDA clearance for its xTAG Gastrointestinal Pathogen Panel (GPP), the first comprehensive molecular diagnostic assay that tests for greater than 90% of bacterial, viral, and parasitic causes of infectious gastroenteritis in a single assay. The xTAG GPP assay can be an important clinical tool in the management of gastrointestinal infections, and is now available in...
AUSTIN, Texas, Jan. 2, 2013 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced that management will present at the 31(st) Annual JP Morgan Healthcare Conference to be held January 7 -10, 2013, in San Francisco, CA. (Logo: http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO) The investor presentation by Patrick J. Balthrop, president and chief executive officer, will begin at 1:30 p.m. Pacific time (4:30 p.m. Eastern time) on Wednesday, January 9, 2013. The...
AUSTIN, Texas, Nov. 27, 2012 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) will host an investor event in New York City on Tuesday, December 11, 2012 beginning at 8am ET, as previously announced on its third quarter financial results conference call. (Logo: http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO) Patrick J. Balthrop, president and chief executive officer, and other members of the executive management team will provide insight into the company's long-term...
